2006
DOI: 10.1038/nature04413
|View full text |Cite
|
Sign up to set email alerts
|

A Cretaceous terrestrial snake with robust hindlimbs and a sacrum

Abstract: It has commonly been thought that snakes underwent progressive loss of their limbs by gradual diminution of their use. However, recent developmental and palaeontological discoveries suggest a more complex scenario of limb reduction, still poorly documented in the fossil record. Here we report a fossil snake with a sacrum supporting a pelvic girdle and robust, functional legs outside the ribcage. The new fossil, from the Upper Cretaceous period of Patagonia, fills an important gap in the evolutionary progressio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
168
2
8

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 165 publications
(189 citation statements)
references
References 13 publications
11
168
2
8
Order By: Relevance
“…2;Tchernov et al, 2000;Apesteguia and Zaher, 2006). These phylogenetic hypotheses stand in stark contrast to the recent findings based on molecular data, which place bolyeriids as sister-taxon to a clade that includes the uropeltines (traditionally considered non-macrostomatan), Acrochordus and colubroids, whereas the tropidophiids were found to be the sister-taxon of the non-macrostomatan genus Anilius (Vidal and Hedges, 2004; see also Vidal and David, 2004).…”
contrasting
confidence: 51%
See 1 more Smart Citation
“…2;Tchernov et al, 2000;Apesteguia and Zaher, 2006). These phylogenetic hypotheses stand in stark contrast to the recent findings based on molecular data, which place bolyeriids as sister-taxon to a clade that includes the uropeltines (traditionally considered non-macrostomatan), Acrochordus and colubroids, whereas the tropidophiids were found to be the sister-taxon of the non-macrostomatan genus Anilius (Vidal and Hedges, 2004; see also Vidal and David, 2004).…”
contrasting
confidence: 51%
“…The Round Island boas Casarea dussumieri and Bolyeria multicarinata are of relatively small size compared to most other booids, yet they are nested deeply inside the latter (Underwood, 1976;Tchernov et al, 2000;Lee and Scanlon, 2002;Apesteguia and Zaher, 2006;Scanlon, 2006). Thus, some degree of paedomorphosis may be expected, as was indeed noted by Anthony and Guibé (1952).…”
Section: Discussionmentioning
confidence: 64%
“…Panels A and B show, respectively, reverse-phase separations of soluble B. lateralis venom proteins recovered after incubation of the venom with rabbit anti-horse IgG antiserum (control sample), and with polyvalent (Crotalinae) antivenom followed by rabbit anti-horse IgG antiserum and immunoprecipitation. HPLC fractions labelled with asterisks in panel A were quantitatively immunodepleted from the venom sample incubated with the polyvalent antivenom, whereas fractions labelled in panel B with numbers (following the same numbering as in Figure 1) were not affected at all (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)20), or were only partially recognized (13)(14)(15)(16)(17)22), by the antivenom (see Figure 7). The insert in panel B shows an SDS-PAGE analysis of -mercaptoethanol-reduced fractions a-g. CID-MS/MS of tryptic peptide ions from these fractions (601.7 2+ : LSVPTSEWQR; 545.6 2+ : VVSTLPI-AHQDWLR; 621.6 3+ : TTPAVLDSDGSYFLYSK) identified them as rabbit IgGs.…”
Section: Clues For Understanding the Envenomation Profiles Ofmentioning
confidence: 99%
“…However, preliminary results from our laboratories indicate that these venoms, like the B. schlegelii venom, contain a large amount of bradykinin-potentiating peptides (BPPs, Table 3). BPPs have been described as snake venom inhibitors of angiotensin-converting enzyme, a dipeptidylcarboxypeptidase expressed in endothelial, epithelial and neuroepithelial cells, which converts inactive angiotensin I into the potent vasoconstrictor angiotensin II, and degrades bradykinin into bradykinin (1-7) or bradykinin (1)(2)(3)(4)(5). 82 BPPs prevent the hypertensive effect of the angiotensin II and potentiate the hypotensive effect of the circulating bradykinin.…”
Section: )Ecesgdccdqcrmentioning
confidence: 99%
See 1 more Smart Citation